GH1 GENE VARIATIONS IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
DOI:
https://doi.org/10.34921/amj.2025.3.06Keywords:
growth hormone deficiency, GH1 gene variationsAbstract
The article presents a study dedicated to the comparative investigation of GH1 gene variations and their prognostic significance in children diagnosed with isolated growth hormone deficiency (IGHD) during the preschool age. The study involved 20 patients diagnosed with IGHD. In these children, the nucleotide sequence of the GH1 gene was examined. In the first main group (children born prematurely with IGHD diagnosed during the preschool age), no pathogenic mutations in the GH1 gene were identified in any of the 10 children. In the comparison group (group II – children born at term with IGHD diagnosed during the preschool age), 5 out of 10 children showed a completely normal GH1 gene sequence. In group I, 9 children likely had benign variants, 1 child had a likely benign variant (presumed benign), and 1 child had an uncertainly significant variant. In group II, 3 children had benign (presumed benign) variants, 1 child had a benign variant, and 1 child had an uncertainly significant variant polymorphism. Based on the statistical results of single nucleotide polymorphism values during the study, the single nucleotide changes rs6171, rs695, rs2005172, and rs11568827 were found to be statistically significant across the groups. These single nucleotide changes are known as mutant GH1 gene polymorphisms to date. However, the rs11568827 single nucleotide change was identified solely in this study. The rs6171 gene polymorphism was found in 8 children in the main group, 4 with homozygous and 4 with heterozygous genotypes (30% of the patients). In the comparison group II, 1 patient (7%) showed the heterozygous genotype. Preterm children showed a statistically significant higher prevalence of this gene variation.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Azerbaijan Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.


